Once-Daily Tenofovir Disoproxil Fumarate in Treatment-Naive Patients With Chronic Hepatitis B and Minimally Raised ALT
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Lancet Infectious Diseases
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Once-Daily Tenofovir Disoproxil Fumarate in Treatment-Naive Taiwanese Patients With Chronic Hepatitis B and Minimally Raised Alanine Aminotransferase (TORCH-B): A Multicentre, Double-Blind, Placebo-Controlled, Parallel-Group, Randomised Trial
Lancet Infect Dis 2021 Jun 01;21(6)823-833, YC Hsu, CY Chen, IW Chang, CY Chang, CY Wu, TY Lee, MS Wu, MJ Bair, JJ Chen, CC Chen, CH Tseng, CM Tai, YT Huang, WH Ku, LR Mo, JT LinFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.